Welcome to LookChem.com Sign In|Join Free
  • or
ethyl 7-methyl-3-phenylimidazo[1,2-a]pyridine-2-carboxylate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

155539-86-9

Post Buying Request

155539-86-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

155539-86-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 155539-86-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,5,5,3 and 9 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 155539-86:
(8*1)+(7*5)+(6*5)+(5*5)+(4*3)+(3*9)+(2*8)+(1*6)=159
159 % 10 = 9
So 155539-86-9 is a valid CAS Registry Number.

155539-86-9Relevant academic research and scientific papers

A mild and novel synthesis of functionalized fused imidazole analogues under environmentally benign reaction media

Babu, B. Madhu,Kumar, G. Santosh,Thakur, Pramod B.,Bangade, Vikas M.,Meshram

supporting information, p. 3473 - 3477 (2014/06/10)

A mild and novel approach is described for the synthesis of functionalized fused imidazole analogues in solvent-free and catalyst-free condition in ionic liquid. The short reaction time, good isolated yields, generality and environmentally benign reaction media are the significant features of this protocol.

Copper(II)/iron(III) co-catalyzed intermolecular diamination of alkynes: Facile synthesis of imidazopyridines

Zeng, Jing,Tan, Yu Jia,Leow, Min Li,Liu, Xue-Wei

supporting information, p. 4386 - 4389 (2012/10/29)

A facile synthesis of imidazo[1,2-α]pyridines has been achieved by copper(II) and iron(III) co-catalyzed C-N bond formation. This reaction involves an intermolecular oxidative diamination of alkynes with high chemoselectivity and regioselectivity.

INDOLIZINE INHIBITORS OF 5-LIPOXYGENASE

-

, (2011/04/24)

Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 155539-86-9